Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

4:20 PM - 4:30 PM PT

348 - Impact of AI-Based Coronary Artery Calcium (CAC) Scores and Heart Dose on Survival in Locally-Advanced Non-Small-Cell Lung Cancer (LA-NSCLC): A Secondary Analysis of RTOG 0617
Speaker: Haldar, Nilanjan, MD, BS - Thomas Jefferson University, Philadelphia, PA
4:25 PM - 4:30 PM PT

1064 - Dosimetric Correlates of Acute Toxicities for Hypofractionated Whole-Breast Irradiation, A Single Institution Retrospective Investigation: Is There a Need to Update the Guidelines?
Speaker: Dumane, Vishruta, PhD - Icahn School of Medicine at Mount Sinai, New York, NY
4:25 PM - 4:30 PM PT

1071 - A Prospective Study to Evaluate the Impact of Radiotherapy Technique - 3DCRT vs. Hippocampal Sparing Volumetric Modulated Arc Therapy (hsVMAT) - on Neurocognitive Function (NCF) in Adults with Grade 2-3 Gliomas
Speaker: Goyal, Shikha, MD, MBBS - Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh
4:25 PM - 4:30 PM PT

1076 - Early Results from a Randomized Phase II Trial Testing Apalutamide and Stereotactic Body Radiation Therapy for Low-Burden Mhspc (NCT05717660)
Speaker: Francolini, Giulio, MD - Azienda Ospedaliera Universitaria Careggi, Firenze, Italy
4:30 PM - 4:35 PM PT

1065 - Patient Reported Outcomes following Accelerated Partial Breast vs. Ultrahypofractionated/Hypofractionated Whole Breast: A Single Institution Comparison Study
Speaker: Rau, Allison, MD, MS - Arthur JE Child Comprehensive Cancer Centre, Calgary, AB
4:30 PM - 4:35 PM PT

1068 - Results of a Randomized Phase 2 Study of a Novel Superoxide Dismutase Mimetic in Patients with Multiple Brain Metastases undergoing Whole-Brain Radiotherapy
Speaker: Kirkpatrick, John, MD, PhD, FASTRO - Duke University Medical Center, Durham, North Carolina
4:30 PM - 4:35 PM PT

1077 - A Dynamic Treatment Strategy for Oligometastatic CSPC: Integrating Molecular Imaging and SBRT to Personalize Systemic Therapy Intensification and De-Intensification
Speaker: Bettoli, Piero, MD, MS - Instituto Nacional del Cancer, Santiago, Region Met
4:30 PM - 4:40 PM PT

344 - Nimotuzumab Plus Concurrent Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma: Updated Follow-up from the Randomized, Phase 3 CC3 Study
Speaker: Wang, Junjie, MD - Peking University Third Hospital, Beijing, Beijing
4:30 PM - 4:40 PM PT

349 - Epicardial Fat as a Radiomic Predictor of Cardiac Outcomes Following Thoracic Radiotherapy for Lung Cancer
Speaker: Jiao, Qiao, MS, BS, BA - Harvard Medical School, Boston, MI
4:40 PM - 4:50 PM PT

345 - The Endoscopy Results of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-Induced Acute Rectal Injury: A Multi-Center, Randomized, Open-Label, Prospective Trial
Speaker: Zhu, Jiawei, MD - Peking Union Medical College Hospital, Beijing, Beijing
4:40 PM - 4:50 PM PT

350 - Dosimetric Parameters of the Heart and its Substructures Predicting Survival and Cardiac Events in Lung Cancer Patients after Radiotherapy: A Systematic Review and Meta-Analysis
Speaker: Wang, Jun, MD, PhD - The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
4:50 PM - 5:00 PM PT

Discussant
Speaker: Chino, Junzo, MD, FASTRO - Duke Cancer Institute, Durham, NC